At this year’s analytica trade fair in Munich, three Fraunhofer Institutes will be presenting a project from pre-competitive research. Biologists, computer scientists and laser experts have developed a process to analyze and select cells and then examine their protein production. In pharmac ... more
Retina-on-a-chip provides powerful tool for studying eye disease
Impact statement: New technology that recreates some of the complexity of the human retina may help scientists study eye disease and screen for drug side effects that harm the eye.
The development of a retina-on-a-chip, which combines living human cells with an artificial tissue-like system, has been described in the open-access journal eLife.
This cutting-edge tool may provide a useful alternative to existing models for studying eye disease and allow scientists to test the effects of drugs on the retina more efficiently.
Many diseases that cause blindness harm the retina, a thin layer of tissue at the back of the eye that helps collect light and relay visual information to the brain. The retina is also vulnerable to harmful side effects of drugs used to treat other diseases such as cancer. Currently, scientists often rely on animals or retina organoids, tiny retina-like structures grown from human stem cells, to study eye diseases and drug side effects. But results from studies in both models often fail to describe disease and drug effects in people accurately. As a result, a team of scientists have tried to recreate a retina for testing purposes using engineering techniques.
“It is extremely challenging, if not almost impossible, to recapitulate the complex tissue architecture of the human retina solely using engineering approaches,” explains Christopher Probst, Postdoctoral Researcher at the Fraunhofer Institute for Interfacial Engineering and Biotechnology in Stuttgart, Germany, and co-lead author of the current study.
To overcome these challenges, the scientists coaxed human pluripotent stem cells to develop into several different types of retina cells on artificial tissue. This tissue recreates the environment that cells would experience in the body and delivers nutrients and drugs to the cells through a system that mimics human blood vessels.
“This combination of approaches enabled us to successfully create a complex multi-layer structure that includes all cell types and layers present in retinal organoids, connected to a retinal pigment epithelium layer,” says co-lead author Kevin Achberger, Postdoctoral Researcher at the Department of Neuroanatomy & Developmental Biology at the Eberhard Karls University of Tübingen, Germany. “It is the first demonstration of a 3D retinal model that recreates many of the structural characteristics of the human retina and behaves in a similar way.”
The team treated their retina-on-the-chip with the anti-malaria drug chloroquine and the antibiotic gentamicin, which are toxic to the retina. They found that the drugs had a toxic effect on the retinal cells in the model, suggesting that it could be a useful tool for testing for harmful drug effects.
“One advantage of this tiny model is that it could be used as part of an automated system to test hundreds of drugs for harmful effects on the retina very quickly,” Achberger says. “Also, it may enable scientists to take stem cells from a specific patient and study both the disease and potential treatments in that individual’s own cells.”
“This new approach combines two promising technologies – organoids and organ-on-a-chip – and has the potential to revolutionise drug development and usher in a new era of personalised medicine,” concludes senior author Peter Loskill, Assistant Professor for Experimental Regenerative Medicine at the Eberhard Karls University of Tübingen, and head of the Fraunhofer Attract group Organ-on-a-Chip at the Fraunhofer Institute for Interfacial Engineering and Biotechnology. His laboratory, which spans the two institutes, is already developing similar organ-on-a-chip technology for the heart, fat, pancreas and more.
- eye disease
Sun rays damage unprotected skin. Substances in medications or lotions applied to the skin can be chemically modified by sun rays to have a toxic effect on the body. An accredited in-vitro test method at Fraunhofer IGB in Stuttgart measures the phototoxic potential of substances or cosmetic ... more
At present, bacteria, fungi or viruses can generally only be detected with certainty by way of elaborate laboratory tests or animal experiments. The food and pharmaceutical industries would like to have faster tests to check their products. Fraunhofer researchers are therefore developing a ... more
Microscopy is at the forefront of the fight against the coronavirus. Special microscopes, which enable scientists to view minute cell structures, are an indispensable tool in the development of vaccines and new therapies. Such equipment comprises not only a microscope with high optical reso ... more
The air we exhale contains information that can assist with the diagnosis of disease. Researchers at the Fraunhofer Project Hub for Microelectronic and Optical Systems for Biomedicine MEOS are now developing solutions designed to enable the analysis of breath gas for this purpose. Although ... more
The need for everyday objects with antiviral surfaces is high due to the COVID 19 pandemic. It is known that the material composition of an object has an influence on the viability of viruses on surfaces. This is where the work of the Fraunhofer IFAM comes in: In cross-disciplinary research ... more
Digitalization and artificial intelligence are changing diagnostics in clinical routine and pharmaceutical research. New IVD devices are coming out, laboratory data is connected to the hospital IT system and AI-based image analysis enables new and efficient processes in digital pathology an ... more
At Fraunhofer IZI-BB we develop analytical and biotechnological solutions for medical issues, animal health, food, cosmetics and the environment. Our research focuses on sample preparation, development of molecular recognition elements and data acquisition as well as miniaturization and aut ... more
Scientists use super-resolution microscopy to study previously undiscovered cellular worlds, revealing nanometer-scale details inside cells. This method revolutionized light microscopy and earned its inventors the 2014 Nobel Prize in Chemistry. In an international collaboration, AI research ... more
Researchers from ETH Zurich and the University of Tübingen have taken a high-resolution look at the structure and function of cell-to-cell connections in filamentous, multicellular cyanobacteria. This enables them to explain how these microorganisms regulate the transport of various substan ... more
Scientists at the University of Tübingen head a new international project to develop an electrochemical sensor to detect and analyze nanoparticles in commercial products. They are found in cosmetics and paints, and even help keep fruit fresh – nanoparticles, with their antimicrobial qualiti ... more
- 1Detect neurodegenerative diseases such as Alzheimer's by a simple eye scan?
- 2Fluorescence microscopy at highest spatial and temporal resolution
- 3The Mechanics of the Immune System
- 4Resolve Biosciences Launches New Era in Single-Cell Spatial Analysis
- 5Quick look under the skin
- 6New ion trap to create the world's most accurate mass spectrometer
- 7How does your computer smell?
- 8Clocking electron movements inside an atom
- 9Sartorius closes 2020 with strong growth
- 10A clear path to better insights into biomolecules
- Scientists discover how bacteria use liquid protein droplets to overcome stress
- New tool can identify harmful blue-green algae
- New deep learning algorithm can pick up genetic mutations and DNA mismatch r ...
- AI helping to quantify enzyme activity
- Scientists gain new understanding of how brain cells talk
- AI helping to quantify enzyme activity
- Eppendorf AG completes conversion to European public limited company
- Artificial intelligence helps to find new natural substances
- Genomic tracking of the COVID-19 pandemic in England
- In neurodegenerative diseases, brain immune cells have a “ravenous appetite” for sugar